FI880282A0 - Menetelmä uusien terapeuttisesti käyttökelpoisten 3-aryyli-5-alkyylisulfinyyli- ja sulfonyyli-4H-1,2,4-triatsolien valmistamiseksi - Google Patents

Menetelmä uusien terapeuttisesti käyttökelpoisten 3-aryyli-5-alkyylisulfinyyli- ja sulfonyyli-4H-1,2,4-triatsolien valmistamiseksi

Info

Publication number
FI880282A0
FI880282A0 FI880282A FI880282A FI880282A0 FI 880282 A0 FI880282 A0 FI 880282A0 FI 880282 A FI880282 A FI 880282A FI 880282 A FI880282 A FI 880282A FI 880282 A0 FI880282 A0 FI 880282A0
Authority
FI
Finland
Prior art keywords
triazoles
alkylsulfinyl
sulfonyl
aryl
preparation
Prior art date
Application number
FI880282A
Other languages
English (en)
Swedish (sv)
Other versions
FI91526B (fi
FI91526C (fi
FI880282A (fi
Inventor
John M Kane
Francis P Miller
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI880282A0 publication Critical patent/FI880282A0/fi
Publication of FI880282A publication Critical patent/FI880282A/fi
Publication of FI91526B publication Critical patent/FI91526B/fi
Application granted granted Critical
Publication of FI91526C publication Critical patent/FI91526C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI880282A 1987-01-27 1988-01-22 Menetelmä uusien terapeuttisesti käyttökelpoisten 3-aryyli-5-alkyylisulfinyyli- ja sulfonyyli-4H-1,2,4-triatsolien valmistamiseksi FI91526C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US706387A 1987-01-27 1987-01-27
US12619187 1987-12-04
US07/126,191 US4900743A (en) 1987-01-27 1987-12-04 3-aryl-5-alkylthio-4H-1,2,4-triazoles
US706387 1996-08-30

Publications (4)

Publication Number Publication Date
FI880282A0 true FI880282A0 (fi) 1988-01-22
FI880282A FI880282A (fi) 1988-07-28
FI91526B FI91526B (fi) 1994-03-31
FI91526C FI91526C (fi) 1994-07-11

Family

ID=26676435

Family Applications (1)

Application Number Title Priority Date Filing Date
FI880282A FI91526C (fi) 1987-01-27 1988-01-22 Menetelmä uusien terapeuttisesti käyttökelpoisten 3-aryyli-5-alkyylisulfinyyli- ja sulfonyyli-4H-1,2,4-triatsolien valmistamiseksi

Country Status (19)

Country Link
US (1) US4900743A (fi)
EP (1) EP0276793B1 (fi)
JP (1) JP2537651B2 (fi)
KR (1) KR960007166B1 (fi)
CN (1) CN1023480C (fi)
AR (1) AR244682A1 (fi)
AU (1) AU601013B2 (fi)
CA (1) CA1312605C (fi)
DE (1) DE3881712T2 (fi)
DK (1) DK171599B1 (fi)
ES (1) ES2058144T3 (fi)
FI (1) FI91526C (fi)
HU (1) HU205747B (fi)
IE (1) IE61188B1 (fi)
IL (1) IL85185A (fi)
NO (1) NO166642C (fi)
NZ (1) NZ223260A (fi)
PH (1) PH24513A (fi)
PT (1) PT86623B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989006125A1 (en) * 1987-12-31 1989-07-13 Smithkline Beckman Corporation 4-aralkyl-5-substituted-1,2,4-triazole-5-thiols
AU644500B2 (en) * 1990-12-20 1993-12-09 Merrell Dow Pharmaceuticals Inc. 3-aryl-5-alkylthio-4h-1,2,4-triazoles for treatment of hyperreflexia due to spinal trauma
DE4339412A1 (de) * 1993-11-18 1995-05-24 Bayer Ag Verfahren und neue Zwischenprodukte zur Herstellung von Triazolinonen
AR032653A1 (es) 2001-02-09 2003-11-19 Telik Inc Inhibidores heterociclicos del trasportador de glicina 2 composiciones farmaceuticas, uso y metodos.
CN1736381B (zh) * 2005-08-11 2010-09-08 沈阳药科大学 吗啉甲基萘满酮用于制备平滑肌解痉剂的用途
KR20110089868A (ko) * 2008-12-12 2011-08-09 아스트라제네카 아베 4-[4-메틸-5-(c1-10알킬티오/c5-10아릴-c1-6알킬티오)-4h-1,2,4-트리아졸-3-일]피리딘을 제조하기 위한 신규 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU193891B (en) * 1984-02-07 1987-12-28 Gyogyszerkutato Intezet Process for production of new derivatives of 1,2,4-triasole

Also Published As

Publication number Publication date
FI91526B (fi) 1994-03-31
IL85185A (en) 1996-03-31
FI91526C (fi) 1994-07-11
ES2058144T3 (es) 1994-11-01
FI880282A (fi) 1988-07-28
CN88100346A (zh) 1988-11-02
DK171599B1 (da) 1997-02-17
DK35488A (da) 1988-07-28
PT86623A (pt) 1988-02-01
IL85185A0 (en) 1988-07-31
PH24513A (en) 1990-07-18
IE61188B1 (en) 1994-10-19
HU205747B (en) 1992-06-29
NZ223260A (en) 1991-07-26
KR960007166B1 (ko) 1996-05-29
DE3881712D1 (de) 1993-07-22
JPS63201176A (ja) 1988-08-19
NO166642B (no) 1991-05-13
HUT47257A (en) 1989-02-28
AU601013B2 (en) 1990-08-30
AR244682A1 (es) 1993-11-30
AU1072888A (en) 1988-07-28
CN1023480C (zh) 1994-01-12
PT86623B (pt) 1993-01-29
US4900743A (en) 1990-02-13
KR880008999A (ko) 1988-09-13
JP2537651B2 (ja) 1996-09-25
EP0276793B1 (en) 1993-06-16
DE3881712T2 (de) 1993-12-23
CA1312605C (en) 1993-01-12
EP0276793A3 (en) 1988-09-21
EP0276793A2 (en) 1988-08-03
NO880337L (no) 1988-07-28
NO880337D0 (no) 1988-01-26
DK35488D0 (da) 1988-01-26
NO166642C (no) 1991-08-21

Similar Documents

Publication Publication Date Title
FI890282A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
ZA887889B (en) Process for the manufacture of 1,1,1-trifluorodichloroethylene and 1,1,1,2-tetrafluorochloroethylene
NO179584C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler
NO180586C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte imidazoler
EP0302020A3 (en) Process for the preparation of 2,2,6,6-tetramethyl-4-piperidyl-amines
NO178619C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler
FI884497A (fi) Menetelmä uusien, aromataasia inhiboivien 4(5)-imidatsolien valmistamiseksi
FI891338A (fi) Parannus menetelmään 2',3'-dideoksi-2',3'-didehydronukleosidien valmistamiseksi
FI881223A0 (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen 9-aminotetrahydroakriinien ja niille läheisten yhdisteiden valmistamiseksi
NO175978C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser
FI895417A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 2'-halometylideeninukleosidien valmistamiseksi
NO173653C (no) Analogifremgangsmaate for fresmstilling av terapeutisk aktive 6-benzoksazinyl-og 6-benzotianzinyl-2,3,4,5-tetrahydropyridazin-3-oner
FI880467A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FI895393A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten alkyylisubstituoitujen 2-alkyyliamiinibentsopyran-6-olien valmistamiseksi
FI91961C (fi) Menetelmä (S)- -etyyli-2-okso-1-pyrrolidiiniasetamidin valmistamiseksi
FI894546A (fi) Menetelmä uusien 2'-halogeenimetylideeni-, 2'-etenylideeni- ja 2'-etynyyliadenosiinijohdannaisten valmistamiseksi
IL82858A0 (en) Process for the preparation of 1,2,5,6,9,10-hexabromo-cyclododecane
NO174203C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive
NO174774C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive benzodiazepiner
FI880282A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 3-aryyli-5-alkyylisulfinyyli- ja sulfonyyli-4H-1,2,4-triatsolien valmistamiseksi
IL86646A (en) Process for the preparation of 5,11-di-and 5,6,11,12-tetraphenylnaphthacenes
FI93216C (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi
IL86848A0 (en) Therapeutically valuable honey compound and process for the manufacture thereof
FI882836A (fi) Menetelmä terapeuttisesti käyttökelpoisen (E)-2-(p-fluorifenetyyli)-3-fluoriallyyliamiinin valmistamiseksi
FI893121A0 (fi) Menetelmä farmakologisesti aktiivisten 6,21-dimetyyli-19-norprogesteronijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: MERRELL DOW PHARMACEUTICALS INC.